저자의 연구 키워드

저자의 연구 키워드

#5-azacytidine

#가이드라인

#갑상샘암

#갑상샘유두모양암

#갑상샘절제

#갑상선

#갑상선결절

#갑상선기능저하증

#갑상선기능항진증

#갑상선분화암

#갑상선암

#갑상선자극 호르몬

#갑상선자극호르몬

#갑상선자극호르몬 억제

#갑상선절제술

#갑상선종양

#갑상선중독증

#갑상선호르몬

#갑상선호르몬 내성증후군.

#검사 시약

#골전이

#관찰

#국소 치료

#국소치료

#권고안

#그레이브스병

#기형종

#뇌전이

#단일광자단층촬영

#단일유전자질환

#담즙

#대사 지표

#대한갑상선학회

#동맥경화

#동시화학방사선요법

#동적위험분류

#등록

#레보타이록신

#림프절전이

#무증상갑상선기능저하증

#미생물무리

#미생물무리유전체

#미세갑상선유두암

#발생률

#방사성요오드

#방사성요오드 치료

#병리학

#보조항암화학요법

#부갑상선기능저하증

#불응성 갑상선암

#비소세포폐암.

#산후갑상선염

#선암

#선천성 갑상선기능저하증

#선천성 갑상선기능항진증

#성대마비

#소아청소년

#수술

#수술 전

#수술 후 합병증

#약제유발

#영상검사

#예후

#외부방사선조사

#원격전이

#위험도 평가

#유두

#유두갑상선암종

#의사결정

#인간유전자재조합 갑상선자극호르몬

#임상적 특징

#임신

#자가면역질환

#자궁내막암

#재발

#재발성

#재발위험

#저칼슘혈증

#적극적 관찰

#전신항암치료

#전이

#지속적위험분류

#지침

#진단

#진단 치료

#진료권고안

#진행성 갑상선분화암

#진행성갑상선분화암

#참고구간

#체성분

#체중

#초음파

#치료

#콜레스테롤

#키나아제 억제제

#폐전이

#한국

#항갑상선제

#ABCG5

#ABCG8

#Active surveillance

#Adenocarcinoma

#Adenoma

#Adjuvant chemotherapy

#Advanced differentiated thyroid carcinoma

#Advanced Papillary Thyroid Cancer

#Adverse events

#Aged

#Aging

#anaplastic

#angiotensin II

#anticancer drug

#Anti-Mullerian hormone

#antiproliferatory effect

#Antithyroid agents

#atherosclerosis

#Autoimmune disease

#bacterial toxin

#Bile

#Bile acids

#Biopsy

#BIRC5 protein

#Bisphenol A

#Body composition

#Bone metastasis

#BRAF

#BRAF 돌연변이

#BRAF mutation

#Brain metastasis

#breast cancer

#Carcinoma

#Cardiometabolic risk factors

#Cardiovascular diseases

#Carotid atherosclerosis

#Cause of death

#cellular transformation

#Cholesterol

#Clinical characteristics

#Clostridium difficile toxin A

#Concurrent chemoradiation

#Congenital hyperthyroidism

#Congenital hypothyroidism

#Cyclooxygenase 2

#Cytotoxic T-lymphocyte-associated antigen 4

#Database

#Diabetes

#Diabetes mellitus

#Diagnosis

#Diagnosis treatment

#Diagnostic test reagents

#Diethylhexyl phthalate

#Differentiated thyroid cancer

#Diffuse parenchymal abnormality

#Distant metastases

#Distant metastasis

#Dose

#Dynamic risk assessment

#Elderly

#Endocrine disruptors

#Endometrial neoplasm

#endothelial dysfunction

#Environmental factor

#Epidemiology

#Epigenomics

#Estrogen receptor

#Exercise

#External beam radiation therapy

#extracellular signalrelated kinases-1/2

#Farnesoid X-activated receptor

#Fine-Needle

#flow-mediated vasodilatation

#follicular

#Follicular adenocarcinoma

#Fusion Outlier

#Gastrointestinal microbiome

#Gene panel

#Genome

#Genomics

#gestational

#Gestational diabetes mellitus

#Glucagon

#Glucagon-like peptide 1

#Glucose-dependent insulinotropic polypeptide

#graves disease

#Graves' disease

#Graves’ disease

#group B

#Guideline

#Guidelines

#Heart valve diseases

#High-throughput nucleotide sequencing

#HLA-DQB1

#HLA-DQB1 antigens

#HLA-DRB1

#HLA-DRB1 antigens

#HOXD9

#human

#Hurthle cell thyroid cancer

#Hypercholesterolemia

#Hyperthyroidism

#Hypocalcemia

#Hypoparathyroidism

#Hypothyroidism

#I-131

#Imaging

#Immediate surgery

#Immune related adverse effect

#Immune Subtyping

#Immune-Es cape Signaling

#Immunoassay

#immunoglobulins

#Incidence

#Indeterminate nodules

#Inhibitor of differentiation protein 1

#Inhibitor of differentiation protein 2

#insulin receptor substrate 1

#Insulin resistance

#Insulin secretion

#Intake

#Iodine

#Iodine radioisotopes

#Iodine-131

#IRAE)

#itochondrial dysfunction

#Korea

#Korean

#Korean Thyroid Association

#Korean Thyroid Cancer

#Lenvatinib

#Levothyroxine

#Local therapy

#Long-term outcomes

#Lung metastasis

#Lymph node metastasis

#Lymph nodes

#Lymphatic metastasis

#Malignancy risk

#Management

#Mass screening

#Mediastinum

#medullary

#Medullary thyroid carcinoma

#melanoma

#member 2

#Menopause

#Metabolic fluxomics

#Metabolic parameter

#metastasis

#Microbiome

#Microbiota

#Mitochondria

#Mitophagy

#Monogenic disorder

#muscle

#NAD+

#Neoplasms

#Nepolasm metastasis

#Non-small-cell lung carcinoma

#nuclear receptor subfamily 0

#Osteoblast

#Osteogenic differentiation

#papillary

#Papillary thyroid cancer

#Papillary thyroid carcinoma

#Papillary thyroid microcarcinoma

#Pathology

#PD-1)

#PD-L1)

#Pediatric

#Peroxisome proliferator-activated receptors

#Persistent disease

#Phospholipase C-γl

#Pioglitazone

#plasminogen activator inhibitor 1

#Polyneuropathy

#Postoperative complications

#Postpartum thyroiditis

#Practice guideline

#Practice guidelines

#prediction model

#Predictive Biomarker

#Pregnancy

#Preoperative

#Prevalence

#proangiogenic macrophages

#Prognosis

#Programmed cell death receptor 1

#Programmed cell death receptor ligand 1

#Prospective studies

#protein-protein interaction

#Quality of life

#Questionnaire

#Radioactive iodine

#Radioactive iodine therapy

#Radioiodine therapy

#Receptors

#receptors thyrotropin

#Recombinant human TSH

#Recommendation

#Recurrence

#Recurrent disease

#Refractory thyroid cancer

#Registries

#Resection rate

#RET

#RET mutation

#retinoid X receptor α

#Risk assessment

#Risk of recurrence

#RNA Sequencing

#Sarcopenia

#Shared decision making

#Short-term hypothyroidism

#Size

#Skeletal muscle

#smooth

#Sodium iodide symporter

#Sodium-iodide symporter

#Somatosensory evoked potential

#Sorafenib

#SPECT CT

#Stable isotope tracers

#Stimulation

#Study protocol

#Subclinical hypothyroidism

#Sunitinib

#Surgery

#Survival analysis

#Systemic therapy

#Telomerase

#Teratoma

#Therapeutics

#Therapy

#Thymus hyperplasia

#Thyroglobulin

#Thyroid

#Thyroid cancer

#Thyroid cancer screening

#Thyroid carcinoma

#Thyroid disease

#Thyroid dysgenesis

#Thyroid function tests

#Thyroid gland

#Thyroid guidelines

#thyroid hormone

#Thyroid hormone resistance syndrome

#Thyroid hormones

#Thyroid imaging reporting and data systems

#Thyroid neopla는

#Thyroid neoplasm

#Thyroid neoplasms

#Thyroid nodule

#Thyroid ultrasound

#Thyroidectomy

#thyroid-stimulating

#Thyroid-stimulating hormone

#Thyroid-stimulating hormone suppression

#Thyrotoxicosis

#Thyrotropin

#Thyroxine

#Total thyroidectomy

#Transcriptome

#transforming growth factor β

#Treatment

#Triiodothyronine

#TSH at therapy

#TSH suppression

#Tumor suppressor protein p53

#Tumor-associated macrophage

#tumor-associated macrophages

#type 2

#Tyrosine kinase inhibitor

#Ultrasonography

#Ultrasound

#Urolithin

#Vandetanib

#vascular

#Vocal fold paralysis

#Watchful waiting

#Weight

#Weight gains

#yrotropin